LIST OF TABLES for the Pharmaceuticals Report

Table 3.1: Annual Sales of the Top Ten Therapy Classes 2003 - 2005
Table 3.2: Top 10 Best Selling Drugs 2003 - 2005
Table 5.1: Major drug withdrawals in 2004 and 2005
Table 8.1: Top ten firms in 2005
Table 8.2: Key Financials: Pfizer Inc. 2003 - 2005
Table 8.3: Top ten products: Pfizer 2005
Table 8.4: Drugs Approved/Launched: Pfizer 2005
Table 8.5: Drugs Pending Regulatory Approval: Pfizer 2005
Table 8.6: Drugs in late stage development: Pfizer 2005
Table 8.7: Key Financials: Johnson & Johnson 2003 - 2005
Table 8.8: Top ten products: Johnson & Johnson 2005
Table 8.9: Drugs Approved/Launched: Johnson & Johnson 2005
Table 8.10: Drugs Pending Regulatory Approval: Johnson & Johnson 2005
Table 8.11: Drugs in late stage development: Johnson & Johnson 2005
Table 8.12: Key Financials: GlaxoSmithKline 2003 - 2005
Table 8.13: Top ten products: GlaxoSmithKline 2005
Table 8.14: Drugs Approved/Launched: GlaxoSmithKline 2005
Table 8.15: Drugs Pending Regulatory Approval: GlaxoSmithKline 2005
Table 8.16: Drugs in late stage development: GlaxoSmithKline 2005
Table 8.17: Key Financials: Sanofi-Aventis 2003 - 2005
Table 8.18: Top ten products: Sanofi-Aventis 2005
Table 8.19: Drugs Approved/Launched: Sanofi-Aventis 2005
Table 8.20: Drugs Pending Regulatory Approval: Sanofi-Aventis 2005
Table 8.21: Drugs in late stage development: Sanofi-Aventis 2005
Table 8.22: Key Financials: Novartis 2003 - 2005
Table 8.23: Top ten products: Novartis 2005
Table 8.24: Drugs Approved/Launched: Novartis 2005
Table 8.25: Drugs Pending Regulatory Approval: Novartis 2005
Table 8.26: Drugs in late stage development: Novartis 2005
Table 8.27: Key Financials: Roche 2003 - 2005
Table 8.28: Top ten products: Roche 2005
Table 8.29: Drugs Approved/Launched: Roche 2005
Table 8.30: Drugs Pending Regulatory Approval: Roche 2005
Table 8.31: Drugs in late stage development: Roche 2005
Table 8.32: Key Financials: AstraZeneca 2003 - 2005
Table 8.33: Top ten products: AstraZeneca 2005
Table 8.34: Drugs Approved/Launched: AstraZeneca 2005
Table 8.35: Drugs Pending Regulatory Approval: AstraZeneca 2005
Table 8.36: Drugs in late development: AstraZeneca 2005
Table 8.37: Key Financials: Merck & Co 2003 - 2005
Table 8.38: Top ten products: Merck & Co 2005
Table 8.39: Drugs Approved/Launched: Merck & Co 2005
Table 8.40: Drugs Pending Regulatory Approval: Merck & Co 2005
Table 8.41: Drugs in late stage development: Merck & Co 2005
Table 8.42: Key Financials: Bristol Myers Squibb 2003 - 2005
Table 8.43: Top ten products: Bristol Myers Squibb 2005
Table 8.44: Drugs Approved/Launched: Bristol Myers Squibb 2005
Table 8.45: Drugs Pending Regulatory Approval: Bristol Myers Squibb 2005
Table 8.46: Drugs in late stage development: Bristol Myers Squibb 2005
Table 8.47: Key Financials: Wyeth 2003 - 2005
Table 8.48: Top ten products: Wyeth 2005
Table 8.49: Drugs Approved/Launched: Wyeth 2005
Table 8.50: Drugs in late stage development: Wyeth 2005
Table 10.1: Top 10 M&A 2005
Table 12.1: Major Pharmaceutical and Biopharmaceutical Drugs Losing Patents in 2006